IRIS
LO CAPUTO, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.596
NA - Nord America 1.022
AS - Asia 100
SA - Sud America 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.018
IE - Irlanda 1.003
SE - Svezia 279
UA - Ucraina 118
IT - Italia 96
CN - Cina 38
VN - Vietnam 34
GB - Regno Unito 30
FI - Finlandia 29
FR - Francia 16
DE - Germania 13
TR - Turchia 11
IR - Iran 4
BE - Belgio 3
CA - Canada 3
IN - India 3
AU - Australia 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
NL - Olanda 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SG - Singapore 2
BR - Brasile 1
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
MX - Messico 1
RO - Romania 1
Totale 2.726
Salva come PNG Salva come JPEG
Città #
Dublin 1.003
Nyköping 208
Chandler 165
Princeton 116
Ashburn 86
Wilmington 73
New York 36
Dong Ket 34
Des Moines 33
Helsinki 25
Dearborn 24
Jacksonville 22
Los Angeles 21
Nanjing 15
Gioia Del Colle 14
Washington 13
Bari 12
London 11
St Louis 10
Norwalk 9
Foggia 7
Ann Arbor 6
Beijing 6
San Mateo 6
Borås 5
Chicago 4
Nanchang 4
Stevenage 4
Boardman 3
Brescia 3
Brussels 3
Hebei 3
Meda 3
Seattle 3
Shenyang 3
Amsterdam 2
Barletta 2
Central 2
Cosenza 2
Gunzenhausen 2
Ningbo 2
Olomouc 2
Redwood City 2
Riyadh 2
Rockville 2
Rome 2
Taizhou 2
Tehran 2
Valmadrera 2
Adelaide 1
Alagoinhas 1
Basel 1
Blackburn 1
Bologna 1
Bucharest 1
Bulgorello 1
Cerignola 1
Chieri 1
Ciampino 1
Clearwater 1
Dallas 1
Frankfurt am Main 1
Garbagnate Milanese 1
Hilden 1
Istanbul 1
Jakarta 1
Komotini 1
Kunming 1
Lencloitre 1
Medellín 1
Melbourne 1
Modena 1
Modugno 1
Mount Royal 1
Mumbai 1
Naples 1
Nuremberg 1
Orland Park 1
Ottawa 1
Phoenix 1
Seoul 1
Tacoma 1
Taiyuan 1
Tokyo 1
Toronto 1
Zhengzhou 1
Totale 2.058
Salva come PNG Salva come JPEG
Nome #
Long-term failure of antiviral activity of Zidovudine therapy in anti-HIV positive subjects 68
Monitoraggio virologico in soggetti con infezione da HIV in trattamento con Zidovudina (AZT) 68
Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy. 68
Prevalence of hepatitis virus infections in Albanian refugees. 64
2Apolipoprotein B mRNA–Editing Enzyme, Catalytic Polypeptide–Like 3G: A PossibleRole in the Resistance to HIV of HIV-1 Exposed Seronegative Individuals 63
Tocilizumab and corticosteroids for covid-19 treatment in elderly patients. Journal of Gerontology and Geriatrics 62
Efficacy and Safety of Remdesivir over Two Waves of the Sars-CoV-2 Pandemic 59
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 52
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 50
Two nasal swabs may not be enough to exclude SARS-CoV-2 infection in symptomatic patients 42
Baricitinib: A chance to treat COVID-19? 41
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): Data from a real-life setting 39
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 38
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users 37
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection 37
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 36
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort 35
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 35
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 35
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort 35
Safety and heart rate changes in Covid-19 patients treated with Remdesivir 35
Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients 34
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection 34
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy 34
Sex and gender differences in COVID-19: an Italian local register- based study 34
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infection 32
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 31
Lost to follow-up: a challenge over 10 years 30
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 30
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection 29
Evaluation of the effect of protective genetic variants on cart success in hiv-1-infected patients 29
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 28
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients 27
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 26
A comprehensive development agenda on tenofovir alafenamide in clinical practice 26
Severity of covid‐19 patients predicted by serum sphingolipids signature 26
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 25
A role for mucosal immunity in resistance to HIV infection 25
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study 25
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort) 25
HIV rapid test in a community setting as a strategy to improve access to HIV testing: Data from a multicentre experience in Italy 25
Twenty Years Later: the Recent Trends of HIV-infection – Evidence from an Italian Region 24
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients 24
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia. 24
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission 24
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 24
A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection 24
. Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 23
A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted Regimens (RADAR) Study 23
. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 23
Italian Consensus Statement on Management of HIV-Infected Individuals with Advanced Disease Naïve to Antiretroviral Therapy 23
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 23
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals 22
Comparison between Rules-Based Human Immunodeficiency Virus Type 1 Genotype Interpretations and Real or Virtual Phenotype: Concordance Analysis and Correlation with Clinical Outcome in Heavily Treated Patients 22
Human Immunodeficiency Virus (HIV)–Specific IgA and HIV Neutralizing Activity in the Serum of Exposed Seronegative Partners of HIV‐Seropositive Persons 22
An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selection. 22
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients 22
Influence of Gender, Age, and Transmission Category on the Progression From HIV Seroconversion to AIDS 22
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals 21
The elderly and direct antiviral agents: Constraint or challenge? 20
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 20
Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation 20
Seroimmunity to poliomyelitis in an Albanian immigrant population 20
RADAR Study Group of MASTER Cohort “Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients 20
Pregnancy Outcomes Among ART-Naive and ART-Experienced HIV-Positive Women: Data From the ICONA Foundation Study Group, Years 1997–2013 19
Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology 19
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing 19
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection 19
Influence of Genotype 3 Hepatitis C Coinfection on Liver Enzyme Elevation in HIV-1-Positive Patients After Commencement of a New Highly Active Antiretroviral Regimen: Results From the EPOKA-MASTER Cohort 19
Prevalence of hepatitis virus infections in Albanian refugees 19
Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infection 18
Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis 18
Health response to a large and rapid influx of Albanian refugees in southern Italy, 1991 18
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors 18
Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy: a randomized clinical trial (2pm Study) 18
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 18
Specific Enfuvirtide Associated Mutational Pathways in HIV-1 Gp41 Are Significantly Correlated With an Increase in CD4+ Cell Count, Despite Virological Failure 18
Enhancing care for people living with HIV: current and future monitoring approaches 18
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men” AIDS 17
Endoplasmic reticulum aminopeptidase 2 haplotypes ply a role in modulating susceptibility to HIV infection 17
Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals 17
Toll-like receptor activation pathways in HIV-1 exposed seronegative individuals 17
PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection 17
The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection 17
Lipid Abnormalities in HIV-Infected Patients Are Not Correlated With Lopinavir Plasma Concentrations 17
Resistance to Dideoxynucleoside Reverse Transcriptase Inhibitors: Genotypic-Phenotypic Correlations 17
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort 17
Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy 17
Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome 17
Risk of Developing Specific AIDS”Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis 17
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years 17
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) 17
Mucosal and Systemic Immune Activation Is Present in Human Immunodeficiency Virus–Exposed Seronegative Women 17
Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic 16
Management of Chronic Hepatitis B in HIV-Coinfected Patients 16
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 16
IL-22 Participates in an Innate Anti-HIV-1 Host-Resistance Network through Acute-Phase Protein Induction 16
The 'immunologic advantage' of HIV-exposed seronegative individuals 16
OKA Regulatory Polymorphism in HAVCR2 Modulates Susceptibility to HIV-1 Infection 16
Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection 16
Totale 2.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.471
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 2 7
2019/202068 12 4 0 3 8 16 12 1 4 1 5 2
2020/2021474 6 2 5 0 6 2 6 2 266 91 11 77
2021/2022492 81 3 3 15 30 26 12 50 63 36 24 149
2022/20231.809 164 27 90 36 35 117 12 62 1.116 94 28 28
2023/2024490 69 34 28 16 31 98 65 13 108 21 7 0
Totale 3.388